Patents by Inventor Nicholas A. Lehman

Nicholas A. Lehman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of Angiogenesis
    Publication number: 20190048314
    Abstract: The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors.
    Type: Application
    Filed: March 8, 2018
    Publication date: February 14, 2019
    Applicant: ABT Holding Company
    Inventors: Juliana Megan Woda, Anthony E. Ting, Nicholas A. Lehman
  • Modulation of Angiogenesis
    Publication number: 20140242629
    Abstract: The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors.
    Type: Application
    Filed: February 25, 2014
    Publication date: August 28, 2014
    Applicant: ABT Holding Company
    Inventors: Juliana Megan Woda, Anthony E. Ting, Nicholas A. Lehman
  • Modulation of Angiogenesis
    Publication number: 20110206647
    Abstract: The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors.
    Type: Application
    Filed: March 25, 2011
    Publication date: August 25, 2011
    Applicant: ABT Holding Company
    Inventors: Juliana Megan Woda, Anthony E. Ting, Nicholas A. Lehman